Abstract: FR-PO0969
Deceased-Donor Kidney Procurement Biopsy Practices: Cohort Study of Trends, Clinical Correlations, and Organ Use
Session Information
- Transplantation: Clinical - Pretransplantation, Living Donation, and Policies
November 07, 2025 | Location: Exhibit Hall, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Transplantation
- 2102 Transplantation: Clinical
Authors
- Lentine, Krista L., Saint Louis University, St. Louis, Missouri, United States
- Caza, Tiffany, Arkana Laboratories, Little Rock, Arkansas, United States
- Mannon, Roslyn B., University of Nebraska Medical Center, Omaha, Nebraska, United States
- Caliskan, Yasar, Saint Louis University, St. Louis, Missouri, United States
- Alhamad, Tarek, Washington University in St Louis, St. Louis, Missouri, United States
- Wellen, Jason, Washington University in St Louis, St. Louis, Missouri, United States
- Axelrod, David, University Hospitals Health System, Cleveland, Ohio, United States
- Husain, Syed Ali, Columbia University, New York, New York, United States
- Mohan, Sumit, Columbia University, New York, New York, United States
- Marklin, Gary F., Mid-America Transplant Services, St. Louis, Missouri, United States
Background
We conducted a retrospective cohort study of deceased donor kidneys (DDK) procured at a U.S. organ procurement organization (OPO) to analyze trends, clinical correlates, biopsy findings, and associations with organ use.
Methods
We examined electronic records for DDK procured for transplant at a Midwestern OPO (2019-07/14/2023). Clinical correlates of procurement biopsy were assessed by multivariable logistic regression (adjusted odds ratio, LCLaORUCL). DDK utilization was compared in biopsied and non-biopsied groups over time. Frozen section findings were compared for transplanted vs. unused DDK (Chi-square test).
Results
Among 2,180 DDK procured for transplant, 56.5% were biopsied, tho rates declined over time (Fig). Donor age (aOR for >60 vs age <18, 1.131.702.66), DCD status (aOR, 1.311.611.97) and KPDI 65+ (aOR, 1.131.302.66) were the strongest correlates of undergoing biopsy, while the adjusted likelihood of biopsy declined over time (aOR for 2022-2023 vs 2019, 0.580.75 0.96). Non-use was more common in biopsied DDK overall (26.7% vs 5.8% in non-biopsied). Non-used DDK had higher proportions of biopsy findings across compartments (Table). Non-use after biopsy did not decline over time (26% in 2023 vs 21% in 2019).
Conclusion
DDK procurement biopsies are frequently performed and are linked to higher rates of organ non-use. While biopsy and utilization patterns are influenced by the selection of higher-risk donor characteristics and associated histopathological findings, temporal trends indicate that biopsy rates may decline with shifts in local practices. Further research should assess whether reducing biopsy rates can decrease organ non-use while maintaining acceptable transplant outcomes.